TY - JOUR
T1 - A cost-effectiveness comparisons of adult spinal deformity surgery in the United States and Japan
AU - International Spine Study Group (ISSG)
AU - Yagi, Mitsuru
AU - Ames, Christopher P.
AU - Keefe, Malla
AU - Hosogane, Naobumi
AU - Smith, Justin S.
AU - Shaffrey, Christopher I.
AU - Schwab, Frank
AU - Lafage, Virginie
AU - Shay Bess, R.
AU - Matsumoto, Morio
AU - Watanabe, Kota
N1 - Publisher Copyright:
© 2017, Springer-Verlag GmbH Germany.
PY - 2018/3/1
Y1 - 2018/3/1
N2 - Purpose: Information about the cost-effectiveness of surgical procedures for adult spinal deformity (ASD) is critical for providing appropriate treatments for these patients. The purposes of this study were to compare the direct cost and cost-effectiveness of surgery for ASD in the United States (US) and Japan (JP). Methods: Retrospective analysis of 76 US and 76 JP patients receiving surgery for ASD with ≥2-year follow-up was identified. Data analysis included preoperative and postoperative demographic, radiographic, health-related quality of life (HRQOL), and direct cost for surgery. An incremental cost-effectiveness ratio (ICER) was determined using cost/quality-adjusted life years (QALY). The cost/QALY was calculated from the 2-year cost and HRQOL data. Results: JP exhibited worse baseline spinopelvic alignment than the US (pelvic incidence and lumbar lordosis: 35.4° vs 22.7°, p OpenSPiltSPi 0.01). The US had more three-column osteotomies (50 vs 16%), and shorter hospital stay (7.9 vs 22.7 days) (p OpenSPiltSPi 0.05). The US demonstrated worse postoperative ODI (41.3 vs. 33.9%) and greater revision surgery rate (40 vs 10%) (p OpenSPiltSPi 0.05). Due to the high initial cost and revision frequency, the US had greater total cost ($92,133 vs. $49,647) and cost/QALY ($511,840 vs. $225,668) at 2-year follow-up (p OpenSPiltSPi 0.05). Conclusion: Retrospective analysis comparing the direct costs and cost-effectiveness of ASD surgery in the US vs JP demonstrated that the total direct costs and cost/QALY were substantially higher in the US than JP. Variations in patient cohort, healthcare costs, revision frequencies, and HRQOL improvement influenced the cost/QALY differential between these countries.
AB - Purpose: Information about the cost-effectiveness of surgical procedures for adult spinal deformity (ASD) is critical for providing appropriate treatments for these patients. The purposes of this study were to compare the direct cost and cost-effectiveness of surgery for ASD in the United States (US) and Japan (JP). Methods: Retrospective analysis of 76 US and 76 JP patients receiving surgery for ASD with ≥2-year follow-up was identified. Data analysis included preoperative and postoperative demographic, radiographic, health-related quality of life (HRQOL), and direct cost for surgery. An incremental cost-effectiveness ratio (ICER) was determined using cost/quality-adjusted life years (QALY). The cost/QALY was calculated from the 2-year cost and HRQOL data. Results: JP exhibited worse baseline spinopelvic alignment than the US (pelvic incidence and lumbar lordosis: 35.4° vs 22.7°, p OpenSPiltSPi 0.01). The US had more three-column osteotomies (50 vs 16%), and shorter hospital stay (7.9 vs 22.7 days) (p OpenSPiltSPi 0.05). The US demonstrated worse postoperative ODI (41.3 vs. 33.9%) and greater revision surgery rate (40 vs 10%) (p OpenSPiltSPi 0.05). Due to the high initial cost and revision frequency, the US had greater total cost ($92,133 vs. $49,647) and cost/QALY ($511,840 vs. $225,668) at 2-year follow-up (p OpenSPiltSPi 0.05). Conclusion: Retrospective analysis comparing the direct costs and cost-effectiveness of ASD surgery in the US vs JP demonstrated that the total direct costs and cost/QALY were substantially higher in the US than JP. Variations in patient cohort, healthcare costs, revision frequencies, and HRQOL improvement influenced the cost/QALY differential between these countries.
KW - Adult spinal deformity
KW - Complication
KW - Cost
KW - Cost-effectiveness
KW - QALY
UR - http://www.scopus.com/inward/record.url?scp=85027984258&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85027984258&partnerID=8YFLogxK
U2 - 10.1007/s00586-017-5274-5
DO - 10.1007/s00586-017-5274-5
M3 - Article
C2 - 28836012
AN - SCOPUS:85027984258
SN - 0940-6719
VL - 27
SP - 678
EP - 684
JO - European Spine Journal
JF - European Spine Journal
IS - 3
ER -